US Stock MarketDetailed Quotes
ATXI Avenue Therapeutics
- 3.5000
- +0.0600+1.74%
Close Jul 11 16:00 ET
- 3.4500
- -0.0500-1.43%
Post 19:40 ET
3.29MMarket Cap0.28P/E (TTM)
3.6000High3.3500Low31.70KVolume3.4800Open3.4400Pre Close110.94KTurnover3.64%Turnover RatioLossP/E (Static)940.99KShares91.500052wk High1.16P/B3.05MFloat Cap3.210052wk Low--Dividend TTM871.53KShs Float13882.2750Historical High--Div YieldTTM7.27%Amplitude3.2100Historical Low3.4990Avg Price1Lot Size
Avenue Therapeutics Stock Forum
Sign in to post a comment
$Avenue Therapeutics(ATXI.US$ Avenue Therapeutics Completes Last Patient Last Visit In Phase 1b/2a Clinical Trial Of AJ201 For Spinal And Bulbar Muscular Atrophy! Top line data expected mid year!
2
2
$Avenue Therapeutics(ATXI.US$Any expert on this company?
1
2
$Avenue Therapeutics(ATXI.US$ Avenue Therapeutics Inc: Announced That It Will Effect a 1-for-75 Reverse Split of Its Issued and Outstanding Common Stock
1
6
good luck
2
1
$Avenue Therapeutics(ATXI.US$ Maxim Group analyst Jason McCarthy maintained a Buy rating on Avenue Therapeutics (ATXI – Research Report) yesterday and set a price target of $0.75.
1
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
DuckDucky : Wait for it to go up